![](/img/cover-not-exists.png)
Final results of a phase II single-institutional trial with hyperfractionated radiation therapy (HFX) and four-weekly continuous cisplatin in locally advanced head and neck carcinoma
Arias, F., Asín, G., Uzcanga, M. I., Maraví, E., Quílez, I., Chicata, V., Eito, C., Viudez, A., Hernández, I., Mañeru, F., Domínguez, M. A.Volume:
16
Language:
english
Journal:
Clinical and Translational Oncology
DOI:
10.1007/s12094-013-1118-x
Date:
June, 2014
File:
PDF, 237 KB
english, 2014